Showing 3,961 - 3,980 results of 74,121 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 0.80s Refine Results
  1. 3961
  2. 3962

    Internet-Delivered Cognitive Behavioral Therapy to Treat Insomnia: A Systematic Review and Meta-Analysis by Michael Seyffert (849995)

    Published 2016
    “…Internet-delivered cognitive behavioral therapy resulted in a decrease in the insomnia severity index by 4.3 points (95% CI: -7.1, -1.5; p = 0.017) compared to control. …”
  3. 3963

    The number of behavioral arrests in DKO mice decreased following systemic atropine. by Mike Kalogiannis (224818)

    Published 2011
    “…<p>(A) Mean (± SEM) time per mouse spent in full behavioral arrests are plotted in 30 min bins across the entire recording period following IP injections of saline (open symbols) and atropine (0.5 mg/kg; filled symbols). …”
  4. 3964
  5. 3965

    SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

    Published 2015
    “…Data are expressed as a mean fold change ± standard error of the mean (SEM) (<i>n</i> = 6), compared to healthy controls (<i>n</i> = 6). …”
  6. 3966
  7. 3967

    Tau phosphorylation is decreased in neurons treated with 20 mM KCl. by Nguyen-Vi Mohamed (323606)

    Published 2017
    “…The phosphorylation of S199/S202, T181, T205 and S404 was not significantly affected by 10mM of KCl treatment whereas the phosphorylation of all these sites was decreased by 20mM of KCl treatment. The signal of the phospho-antibodies was normalized to that of total Tau (n = 5, mean ± SEM, unpaired t-test two-tailed, *<i>P</i> < 0.05, ***<i>P</i> < 0.001). …”
  8. 3968
  9. 3969
  10. 3970
  11. 3971
  12. 3972
  13. 3973
  14. 3974

    Twenty-two identified and replicated loci and their overlap with associations to metabolic traits and clinical phenotypes. by Johannes Raffler (793347)

    Published 2015
    “…<p><sup>a</sup> SNP with the strongest association to targeted metabolic traits (“lead SNP”)</p><p><sup>b</sup> SNP with the strongest association to non-targeted metabolic traits</p><p><sup>c</sup> manually added to the list of most plausible candidate genes derived by evidence-based selection</p><p><sup>d</sup> additional candidates match to other non-targeted traits that also associate with the lead SNP</p><p><sup>e</sup> results from GWAS (<i>P</i> < 5.0×10<sup>−8</sup>)</p><p><sup>f</sup> mutations determined in clinical studies</p><p>For each locus, we selected all variants that displayed genome-wide significant association signals to metabolic traits in the SHIP-0 cohort. …”
  15. 3975
  16. 3976
  17. 3977
  18. 3978
  19. 3979

    GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

    Published 2021
    “…GSK343 treatment resulted in significantly decreased viability. (B) COA3 and COA6 (1.5 × 10<sup>3</sup>) cells were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and proliferation was measured using CellTiter<sup>®</sup> assay. …”
  20. 3980